Skip to main content
Fig. 15 | BMC Genomics

Fig. 15

From: Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target

Fig. 15

Correlation between the expression of CYR61 and OS, PFS, PPS of serous OC patients treated with platin-based chemotherapy in TCGA (A), GSE9891 (B) and GSE 26193 (C), which were displayed by 2 Affy ID (201289_at, 210764_s_at). Almost all of the P-values were less than 0.05. Using GEPIA 2, the positive correlation between CYR61 and CALD1 was further confirmed (D). The high degree of correlation between the two genes is striking (P = 6.5e-62, R = 0.69)

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us